Field Evaluation of an Improved Assay Using a Heat-Dissociated p24 Antigen for Adults Mainly Infected With HIV-1 CRF02_AG Strains in Côte d'Ivoire, West Africa

Journal of Acquired Immune Deficiency Syndromes

Volumn 34, Issue 3, 2003, Pages 267-273

  Bonard, Dominique ^a,b,c,f   Rouet, F ^a,b   Toni, T A ^a,c   Minga, A ^a   Huet, C ^a   Ekouevi D K ^d   Dabis, F ^d   Salamon, R ^d   Rouzioux, C ^e  

^a Programme PAC CI/Primo CI ANRS 1220   (Côte d’Ivoire)

^b Ctr Diagn et de Rech sur le SIDA   (Côte d’Ivoire)

^c Ctr Integre Rech Bioclin Abidjan   (Côte d’Ivoire)

^d INSERM   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

^f CENTRE HOSPITALIER UNIVERSITAIRE DE TREICHVILLE   (Côte d’Ivoire)

Author keywords

Heat dissociated p24 antigen; HIV 1 RNA load; Sub Saharan Africa

Indexed keywords

ANTIGEN P24; INDINAVIR; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; VIRUS RNA;

ADULT; AFRICA; ARTICLE; ASSAY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VIRUS LOAD; VIRUS STRAIN;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; COTE D'IVOIRE; DRUG COMBINATIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIV ANTIBODIES; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; INDINAVIR; LAMIVUDINE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; ZIDOVUDINE;

EID: 0242496510     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200311010-00002     Document Type: Article

References (20)

1. Schupbach J, Flepp M, Pontelli D, et al. Heat-mediated immune complex dissociation and enzyme linked immunosorbent assay signal amplification render p24 antigen detection in plasma as sensitive as HIV-1 RNA detection by polymerase chain reaction. AIDS. 1996;10:1085-1090.
2. Boni J, Opravil O, Tomasik Z, et al. Simple monitoring of antiretroviral therapy with a signal-amplification-boosted HIV-1 p24 antigen assay with heat-denatured plasma. AIDS. 1997;11:F47-F52.
3. Rich KC, Janda W, Kalish LA, et al. Immune complex-dissociated p24 antigen in congenital or perinatal HIV infection: role in the diagnosis and assessment of risk of infection in infants. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;15:198-203.
4. Nadal D, Böni J, Kind C, et al. Prospective evaluation of amplification-boosted ELISA for heat-denatured p24 antigen for diagnosis and monitoring of pediatric human immunodeficiency virus type 1 infection. J Infect Dis. 1999;180:1089-1095.
5. Ledergerber B, Flepp M, Böni J, et al. Human immunodeficiency virus type 1 p24 concentration measured by boosted ELISA of heat-denatured plasma correlates with decline in CD4 cells, progression to AIDS, and survival: comparison with viral RNA measurement. J Infect Dis. 2000;181:1280-1287.
6. Schupbach J, Tomasik Z, Nadal D, et al. Use of HIV-1 p24 as a sensitive, precise and inexpensive marker for infection, disease progression and treatment failure. Int J Antimicrob Agents. 2000;16:441-445.
7. Schupbach J, Boni J, Flepp M, et al. Antiretroviral treatment monitoring with an improved HIV-1 p24 antigen test: an inexpensive alternative to tests for viral RNA. J Med Virol. 2001;65:225-232.
8. Sterling TR, Hoover DR, Astemborski J, et al. Heat-denatured human immunodeficiency virus type 1 protein 24 antigen: prognostic value in adults with early-stage disease. J Infect Dis. 2002;186:1181-1185.
9. Bürgisser P, Vemazza P, Flepp M, et al. Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1. J Acquir Immune Defic Syndr Hum Retrovirol. 2000;23:138-144.
10. Pascual A, Cachafeiro A, Funk ML, et al. Comparison of an assay using signal amplification of the heat-dissociated p24 antigen with the Roche Monitor human immunodeficiency virus RNA assay. J Clin Microbiol. 2002;40:2472-2475.
11. Lyamuya E, Bredberg-Raden U, Massawe A, et al. Performance of a modified HIV-1 p24 antigen assay for early diagnosis of HIV-1 infection in infants and prediction of mother-to-infant. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;12:421-426.
12. Guay LA, Hom DL, Kabengera SR, et al. HIV-1 ICD p24 antigen detection in Ugandan infants: use in early diagnosis of infection and as a marker of disease progression. J Med Virol. 2000;62:426-434.
13. Toni TD, Masquelier B, Bonard D, et al. Primary HIV-1 drug resistance in Abidjan (Cote d'Ivoire): a genotypic and phenotypic study. AIDS. 2002;16:488-491.
14. Salamon R, Marimoutou C, Ekra D, et al. Clinical and biological evolution of HIV-1 seroconverters in Abidjan, Cote d'Ivoire, 1997-2000. J Acquir Immune Defic Syndr Hum Retrovirol. 2002;29:149-157.
15. Diop Y, Bonard D, Ba-Gomis O, et al. Prospective trial of CBV + IDV in West Africa [abstract 492]. 8th Conference on Retroviruses and Opportunistic Infections (CROI); Chicago; 2001.
16. Giacomini M, McDermott JL, Giri AA, et al. A novel and innovative kinetic software for virologic colorimetric assays. J Virol Methods. 1998;73:201-209.
17. Janvier B, Baillou A, Archinard P. Immune response to a major epitope of p24 during infection with human immunodeficiency virus type 1 and implications for diagnosis and prognosis. J Clin Microbiol. 1991;29:488-492.
18. Croxson TS, Mathur-Wagh U, Handwerger S, et al. Prognostic significance of quantitative levels of HIV p24 binding capacity in HIV infection. AIDS Res Hum Retroviruses. 1990;6:455-463.
19. Respess R, Cachafeiro A, Fiscus S, et al. Evaluation of a commercially available ultrasensitive p24 antigen viral load assay in samples from patients infected with genetically diverse HIV-1 from different geographic settings [abstract 669]. 10th Conference on Retroviruses and Opportunistic Infections (CROI); Boston; 2003.
20. Mellors JW, Gupta P, et al. Plasma viral load and CD4+ lymphocytes as prognosis markers of HIV-1 infection. Ann Intern Med. 1997;126:946-954.